Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362758 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cyclin-Dependent Kinase 1 (CDK1) antibody
- Antibody type
- Polyclonal
- Antigen
- Cyclin-Dependent Kinase 1 (CDK1)
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Antigen sequence
The antiserum was produced against
synthesized non-phosphopeptide deri
ved fromhuman CDC2 around the phosp
horylation site of threonine161 (T-
Y-T P -H-E).- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- 50 ug/ 50 uL
Submitted references p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells.
Inhibition of cdk2 activating phosphorylation by mevastatin.
Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
Liu Y, Wu C, Galaktionov K
The Journal of biological chemistry 2004 Feb 6;279(6):4507-14
The Journal of biological chemistry 2004 Feb 6;279(6):4507-14
Inhibition of cdk2 activating phosphorylation by mevastatin.
Ukomadu C, Dutta A
The Journal of biological chemistry 2003 Feb 14;278(7):4840-6
The Journal of biological chemistry 2003 Feb 14;278(7):4840-6
Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.
Morris MC, Gondeau C, Tainer JA, Divita G
The Journal of biological chemistry 2002 Jun 28;277(26):23847-53
The Journal of biological chemistry 2002 Jun 28;277(26):23847-53
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA
The Journal of biological chemistry 1999 Mar 26;274(13):8746-56
The Journal of biological chemistry 1999 Mar 26;274(13):8746-56
No comments: Submit comment
No validations: Submit validation data